Huntington Ingalls Industries Inc vs Tilray Brands Inc — how do they compare? Huntington Ingalls Industries Inc trades at $328.1 (market cap $12.92B), while Tilray Brands Inc trades at $4.76 (market cap $649.42M). The key difference: Huntington Ingalls Industries Inc is far larger — about 19.9× Tilray Brands Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.68% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| HII | TLRY | |
|---|---|---|
Market Cap | $12.92B | $649.42M |
Sector | Technology | Health |
52-Week High | $453.73 | $21.00 |
52-Week Low | $265.40 | $3.88 |
Enterprise Value | $15.84B | $816.55M |
Dividend Yield | 1.68% | — |
Signals from Pluang's Aura AI — not financial advice
HII trades at $328.43, down 0.72% today, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $5.27 versus $3.79 expected, and revenue growth of 10.9%. Recent news includes a $2.2 billion contract award for surveillance and intelligence capabilities, enhancing its defense portfolio. Valuation ratios show a P/E of 19.53 and P/S of 0.98, indicating reasonable pricing relative to earnings and sales.
Outlook is positive due to contract wins and operational improvements, but risks include political headwinds and execution challenges. Analyst consensus price target is $359.67, suggesting 9.5% upside. Investment opportunity lies in margin expansion from submarine contracts, while monitoring defense budget volatility is key.
TLRY trades at $4.77, up 7.92% in the last session, with a bullish technical signal from moving averages but mixed oscillators. The company reported record fiscal 2026 revenue of $915 million (GlobeNewsWire, July 28, 2026) but posted a net loss. Key financials show a low P/S of 0.58 and P/B of 0.4, yet profitability remains challenged with negative net income margins and ROE.
Outlook is cautiously optimistic due to revenue growth and diversification into beverages and wellness, but high execution risk persists from consistent losses and competitive pressures. Analyst sentiment is mixed with 25% buy ratings, suggesting potential upside if profitability improves, though near-term volatility is likely.
Trailing returns across standard periods
Latest headlines on both assets
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →